Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation

Toxicology

Volumn 289, Issue 1, 2011, Pages 38-44

  Gelain, Daniel Pens ^a   De Bittencourt Pasquali, Matheus Augusto ^a   Caregnato, Fernanda Freitas ^a   Moreira, José Claudio Fonseca ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Akt; Oxidative stress; P38; RAGE; Retinol

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIOXIDANT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RETINOL; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATTERN RECOGNITION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAGE; RAT; REGULATORY MECHANISM; SPECIES; UPREGULATION;

ANIMALS; CELL SURVIVAL; CHROMONES; ENZYME ACTIVATION; FEMALE; FREE RADICAL SCAVENGERS; IMIDAZOLES; MALE; MORPHOLINES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PREGNANCY; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; RATS; RECEPTORS, IMMUNOLOGIC; SERTOLI CELLS; UP-REGULATION; VITAMIN A;

EID: 80051817292     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.07.008     Document Type: Article

References (54)

1. Krinsky N.I., Johnson E.J. Carotenoid actions and their relation to health and disease. Mol. Aspects Med. 2005, 26:459-516.
2. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, Oxford.
3. Masia S., Alvarez S., de Lera A.R., Barettino D. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol. Endocrinol. 2007, 21:2391-2402.
4. Canon E., Cosgaya J.M., Scsucova S., Aranda A. Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol. Biol. Cell 2004, 15:5583-5592.
5. Gelain D.P., Cammarota M., Zanotto-Filho A., de Oliveira R.B., Dal-Pizzol F., Izquierdo I., Bevilaqua L.R., Moreira J.C. Retinol induces the ERK1/2-dependent phosphorylation of CREB through a pathway involving the generation of reactive oxygen species in cultured Sertoli cells. Cell Signal. 2006, 18:1685-1694.
6. Miloso M., Villa D., Crimi M., Galbiati S., Donzelli E., Nicolini G., Tredici G. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J. Neurosci. Res. 2004, 75:241-252.
7. Mongan N.P., Gudas L.J. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 2007, 75:853-870.
8. Omenn G.S., Goodman G., Grizzle J., Thornquist M., Rosenstock L., Barnhart S., Anderson G., Balmes J., Cherniack M., Cone J., et al. CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers. Anticancer Drugs 1991, 2:79-86.
9. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996, 334:1150-1155.
10. The ABC-Cancer Prevention Study Group, 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N. Engl. J. Med. 330, 1029-1035.
11. Dal-Pizzol F., Klamt F., Frota M.L., Moraes L.F., Moreira J.C., Benfato M.S. Retinol supplementation induces DNA damage and modulates iron turnover in rat Sertoli cells. Free Radic. Res. 2000, 33:677-687.
12. Gelain D.P., Moreira J.C., Bevilaqua L.R., Dickson P.W., Dunkley P.R. Retinol activates tyrosine hydroxylase acutely by increasing the phosphorylation of serine40 and then serine31 in bovine adrenal chromaffin cells. J. Neurochem. 2007, 103:2369-2379.
13. Yan S.D., Stern D., Schmidt A.M. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur. J. Clin. Invest. 1997, 27:179-181.
14. Lukic I.K., Humpert P.M., Nawroth P.P., Bierhaus A. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy. Ann. N.Y. Acad. Sci. 2008, 1126:76-80.
15. Maczurek A., Shanmugam K., Munch G. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Ann. N.Y. Acad. Sci. 2008, 1126:147-151.
16. Bopp C., Bierhaus A., Hofer S., Bouchon A., Nawroth P.P., Martin E., Weigand M.A. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 2008, 12:201.
17. Creagh-Brown B.C., Quinlan G.J., Evans T.W., Burke-Gaffney A. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?. Intensive Care Med. 2010, 36:1644-1656.
18. Hogarth C.A., Griswold M.D. The key role of vitamin A in spermatogenesis. J. Clin. Invest. 2010, 120:956-962.
19. Gelain D.P., de Bittencourt Pasquali M.A., Caregnato F.F., Zanotto-Filho A., Moreira J.C. Retinol up-regulates the receptor for advanced glycation endproducts (RAGE) by increasing intracellular reactive species. Toxicol. In Vitro 2008, 22:1123-1127.
20. Pasquali M.A., Gelain D.P., Zanotto-Filho A., de Souza L.F., de Oliveira R.B., Klamt F., Moreira J.C. Retinol and retinoic acid modulate catalase activity in Sertoli cells by distinct and gene expression-independent mechanisms. Toxicol. In Vitro 2008, 22:1177-1183.
21. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
22. Dar A.C., Shokat K.M. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling 2010, Annu. Rev. Biochem.
23. Zanotto-Filho A., Cammarota M., Gelain D.P., Oliveira R.B., Delgado-Canedo A., Dalmolin R.J., Pasquali M.A., Moreira J.C. Retinoic acid induces apoptosis by a non-classical mechanism of ERK1/2 activation. Toxicol. In Vitro 2008, 22:1205-1212.
24. Zanotto-Filho A., Gelain D.P., Schroder R., Souza L.F., Pasquali M.A., Klamt F., Moreira J.C. The NF kappa B-mediated control of RS and JNK signaling in vitamin A-treated cells: duration of JNK-AP-1 pathway activation may determine cell death or proliferation. Biochem. Pharmacol. 2009, 77:1291-1301.
25. Gelain D.P., de Bittencourt Pasquali M.A., Zanotto-Filho A., de Souza L.F., de Oliveira R.B., Klamt F., Moreira J.C. Retinol increases catalase activity and protein content by a reactive species-dependent mechanism in Sertoli cells. Chem. Biol. Interact. 2008, 174:38-43.
26. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2008, CD007176.
27. Lee H.P., Casadesus G., Zhu X., Lee H.G., Perry G., Smith M.A., Gustaw-Rothenberg K., Lerner A. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev. Neurother. 2009, 9:1615-1621.
28. Omenn G.S., Goodman G., Thornquist M., Grizzle J., Rosenstock L., Barnhart S., Balmes J., Cherniack M.G., Cullen M.R., Glass A., et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res. 1994, 54:s2038-2043s.
29. Pasquali M.A., Gelain D.P., de Oliveira M.R., Behr G.A., da Motta L.L., da Rocha R.F., Klamt F., Moreira J.C. Vitamin A supplementation for different periods alters oxidative parameters in lungs of rats. J. Med. Food 2009, 12:1375-1380.
30. Pasquali M.A., Gelain D.P., Oliveira M.R., Behr G.A., Motta L.L., Rocha R.F., Klamt F., Moreira J.C. Vitamin A supplementation induces oxidative stress and decreases the immunocontent of catalase and superoxide dismutase in rat lungs. Exp. Lung Res. 2009, 35:427-438.
31. Pasquali M.A., Schnorr C.E., Feistauer L.B., Gelain D.P., Moreira J.C. Vitamin A supplementation to pregnant and breastfeeding female rats induces oxidative stress in the neonatal lung. Reprod. Toxicol. 2010, 30:452-456.
32. Gelain D.P., Moreira J.C. Evidence of increased reactive species formation by retinol, but not retinoic acid, in PC12 cells. Toxicol. In Vitro 2008, 22:553-558.
33. Gimeno A., Zaragoza R., Vivo-Sese I., Vina J.R., Miralles V.J. Retinol, at concentrations greater than the physiological limit, induces oxidative stress and apoptosis in human dermal fibroblasts. Exp. Dermatol. 2004, 13:45-54.
34. Murata M., Kawanishi S. Oxidative DNA damage by vitamin A and its derivative via superoxide generation. J. Biol. Chem. 2000, 275:2003-2008.
35. Dal-Pizzol F., Klamt F., Benfato M.S., Bernard E.A., Moreira J.C. Retinol supplementation induces oxidative stress and modulates antioxidant enzyme activities in rat sertoli cells. Free Radic. Res. 2001, 34:395-404.
36. Sanborn B.M., Caston L.A., Buzek S.W., Ussuf K.K. Hormonal regulation of Sertoli cell function. Adv. Exp. Med. Biol. 1987, 219:561-588.
37. Ross A.C. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. FASEB J. 1993, 7:317-327.
38. Ross A.C., Zolfaghari R., Weisz J. Vitamin A: recent advances in the biotransformation, transport, and metabolism of retinoids. Curr. Opin. Gastroenterol. 2001, 17:184-192.
39. Vicente C.P., Fortuna V.A., Margis R., Trugo L., Borojevic R. Retinol uptake and metabolism, and cellular retinol binding protein expression in an in vitro model of hepatic stellate cells. Mol. Cell. Biochem. 1998, 187:11-21.
40. Klamt F., Dal-Pizzol F., Bernard E.A., Moreira J.C. Enhanced UV-mediated free radical generation; DNA and mitochondrial damage caused by retinol supplementation. Photochem. Photobiol. Sci. 2003, 2:856-860.
41. Klamt F., Dal-Pizzol F., Roehrs R., de Oliveira R.B., Dalmolin R., Henriques J.A., de Andrades H.H., de Paula Ramos A.L., Saffi J., Moreira J.C. Genotoxicity, recombinogenicity and cellular preneoplasic transformation induced by vitamin A supplementation. Mutat. Res. 2003, 539:117-125.
42. Allen L.H., Haskell M. Estimating the potential for vitamin A toxicity in women and young children. J. Nutr. 2002, 132:2907S-2919S.
43. Srikanth V., Maczurek A., Phan T., Steele M., Westcott B., Juskiw D., Munch G. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol. Aging 2009.
44. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin, mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
45. Sajithlal G., Huttunen H., Rauvala H., Munch G. Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells. J. Biol. Chem. 2002, 277:6888-6897.
46. Stern D., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 2002, 54:1615-1625.
47. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274:19919-19924.
48. Acin-Perez R., Hoyos B., Zhao F., Vinogradov V., Fischman D.A., Harris R.A., Leitges M., Wongsiriroj N., Blaner W.S., Manfredi G., Hammerling U. Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J. 2010, 24:627-636.
49. Liou J.C., Ho S.Y., Shen M.R., Liao Y.P., Chiu W.T., Kang K.H. A rapid, nongenomic pathway facilitates the synaptic transmission induced by retinoic acid at the developing synapse. J. Cell Sci. 2005, 118:4721-4730.
50. Castaneda C.A., Cortes-Funes H., Gomez H.L., Ciruelos E.M. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev. 2010, 29:751-759.
51. Han J., Sun P. The pathways to tumor suppression via route p38. Trends Biochem. Sci. 2007, 32:364-371.
52. Dal-Pizzol F., Klamt F., Dalmolin R.J., Bernard E.A., Moreira J.C. Mitogenic signaling mediated by oxidants in retinol treated Sertoli cells. Free Radic. Res. 2001, 35:749-755.
53. Dalmolin R.J., Zanotto-Filho A., De Oliveira R.B., Duarte R.F., Pasquali M.A., Moreira J.C. Retinol and retinoic acid increase MMP-2 activity by different pathways in cultured Sertoli cells. Free Radic. Res. 2007, 41:1338-1347.
54. Kang R., Tang D., Livesey K.M., Schapiro N., Lotze M.T., Zeh H.J. The receptor for advanced glycation end-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid. Redox. Signal. 2010.